Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

Barron’s 2024 Healthcare Roundtable panelists make the case for 21 healthcare companies of all stripes, including Humana, Novo Nordisk, BioLife Solutions, and more.

My title is Senior Features Writer, which is a license to write about absolutely anything if I can connect it to technology (I can). I’ve been at PCMag since 2011 and have covered the ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

Short interest in Eli Lilly and Co (NYSE:LLY) increased during the last reporting period, rising from 6.27M to 6.58M. This put 0.82% of the company's publicly available shares short. Short ...

Earnings Report 4.488 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.399 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.600 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Eli Lilly and Company (LLY) current and estimated P/E ratio data provided by Seeking Alpha.

VTYX Stock Rises on Strategic Equity Investment Deal With SNY Shares of Ventyx Biosciences (NASDAQ: VTYX) gained 7% on Monday after the company announced that it has entered into a $27 million ...